Renaissance BioScience Corp.-preview

Renaissancebioscience

Renaissance BioScience Corp.

Private

Vancouver, British ColumbiaFrontier & Industrial Techhttps://renaissancebioscience.com/

Last Round

Grant

Feb 19, 2026

Total Funding Raised

$10.1M

Momentum Score

50 /100

Company Overview

Renaissance BioScience Corp. is a bioengineering company that develops a platform for creating sustainable products in the food, agriculture, and health sectors using yeast.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

yeast engineeringsynthetic biologyacrylamide-reducing yeastRNAi delivery platformbiopesticidessynbiofood ingredientscrop protectioncustom strain developmentcell factoryfunctional microorganismsnon-GMO yeastVLP RNA deliveryfermentation yeast

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Renaissance BioScience Corp. Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Renaissance BioScience Corp. Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Feb 19, 2026
Grant	Sep 9, 2025
Grant	Feb 8, 2024
Convertible Debt	Jun 30, 2023
Grant	Dec 3, 2021
Convertible Debt	Nov 4, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

John Husnik

CSO And Office Of The CEO

Executive Team

Renaissance BioScience Corp. Investors

Notable investors and investment history

Investor	Rounds
Genome British Columbia	Grant
Canadian Food Innovation Network	Grant
National Research Council Canada Industrial Research Assistance Program	Grant
Government of Canada	Grant
Mitacs	Grant
Agriculture and Agri-Food Canada	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 19, 2026
$402K grant round led by Genome British Columbia.
Jan 2, 2026
Monthly visitors grew 134% MoM, reaching 1.8K.

View all signals

Renaissance BioScience Corp. Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Renaissance BioScience Corp. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Renaissance BioScience Corp.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver, British Columbia

Employee Range24

Year Founded2013

Last FundingFeb 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.